Detalhe da pesquisa
1.
A randomized, controlled phase II trial of neoadjuvant ado-trastuzumab emtansine, lapatinib, and nab-paclitaxel versus trastuzumab, pertuzumab, and paclitaxel in HER2-positive breast cancer (TEAL study).
Breast Cancer Res;
21(1): 100, 2019 09 02.
Artigo
em Inglês
| MEDLINE
| ID: mdl-31477168
2.
Umbralisib, a novel PI3Kδ and casein kinase-1ε inhibitor, in relapsed or refractory chronic lymphocytic leukaemia and lymphoma: an open-label, phase 1, dose-escalation, first-in-human study.
Lancet Oncol;
19(4): 486-496, 2018 04.
Artigo
em Inglês
| MEDLINE
| ID: mdl-29475723
3.
Personalized Medicine in Nasal Delivery: The Use of Patient-Specific Administration Parameters To Improve Nasal Drug Targeting Using 3D-Printed Nasal Replica Casts.
Mol Pharm;
15(4): 1392-1402, 2018 04 02.
Artigo
em Inglês
| MEDLINE
| ID: mdl-29485888
4.
A phase 1/2 trial of ublituximab, a novel anti-CD20 monoclonal antibody, in patients with B-cell non-Hodgkin lymphoma or chronic lymphocytic leukaemia previously exposed to rituximab.
Br J Haematol;
177(2): 243-253, 2017 04.
Artigo
em Inglês
| MEDLINE
| ID: mdl-28220479
5.
Pharmacokinetic Analysis and in Vivo Antitumor Efficacy of Taccalonolides AF and AJ.
J Nat Prod;
80(2): 409-414, 2017 02 24.
Artigo
em Inglês
| MEDLINE
| ID: mdl-28112516
6.
Fungal metabolite ophiobolin A as a promising anti-glioma agent: In vivo evaluation, structure-activity relationship and unique pyrrolylation of primary amines.
Bioorg Med Chem Lett;
25(20): 4544-8, 2015 Oct 15.
Artigo
em Inglês
| MEDLINE
| ID: mdl-26341136
7.
Pharmacogenomic diversity of tamoxifen metabolites and estrogen receptor genes in Hispanics and non-Hispanic whites with breast cancer.
Breast Cancer Res Treat;
148(3): 571-80, 2014 Dec.
Artigo
em Inglês
| MEDLINE
| ID: mdl-25395315
8.
A first-in-human dose-escalation study of ME-143, a second generation NADH oxidase inhibitor, in patients with advanced solid tumors.
Invest New Drugs;
32(1): 87-93, 2014 Feb.
Artigo
em Inglês
| MEDLINE
| ID: mdl-23525756
9.
Buparlisib in Patients With Recurrent Glioblastoma Harboring Phosphatidylinositol 3-Kinase Pathway Activation: An Open-Label, Multicenter, Multi-Arm, Phase II Trial.
J Clin Oncol;
37(9): 741-750, 2019 03 20.
Artigo
em Inglês
| MEDLINE
| ID: mdl-30715997
10.
Targeted therapies for metastatic renal cell carcinoma: an overview of toxicity and dosing strategies.
Oncologist;
13(10): 1084-96, 2008 Oct.
Artigo
em Inglês
| MEDLINE
| ID: mdl-18838439
11.
Neurooncology clinical trial design for targeted therapies: lessons learned from the North American Brain Tumor Consortium.
Neuro Oncol;
10(4): 631-42, 2008 Aug.
Artigo
em Inglês
| MEDLINE
| ID: mdl-18559968
12.
Progression-free survival: an important end point in evaluating therapy for recurrent high-grade gliomas.
Neuro Oncol;
10(2): 162-70, 2008 Apr.
Artigo
em Inglês
| MEDLINE
| ID: mdl-18356283
13.
A phase II trial of rebeccamycin analogue (NSC #655649) in children with solid tumors: a Children's Oncology Group study.
Pediatr Blood Cancer;
50(3): 577-80, 2008 Mar.
Artigo
em Inglês
| MEDLINE
| ID: mdl-17610262
14.
Pharmacokinetic and tumor distribution characteristics of temsirolimus in patients with recurrent malignant glioma.
Clin Cancer Res;
13(24): 7401-6, 2007 Dec 15.
Artigo
em Inglês
| MEDLINE
| ID: mdl-18094423
15.
Does intraosseous equal intravenous? A pharmacokinetic study.
Am J Emerg Med;
26(1): 31-8, 2008 Jan.
Artigo
em Inglês
| MEDLINE
| ID: mdl-18082778
16.
A Repurposed Drug for Brain Cancer: Enhanced Atovaquone Amorphous Solid Dispersion by Combining a Spontaneously Emulsifying Component with a Polymer Carrier.
Pharmaceutics;
10(2)2018 May 19.
Artigo
em Inglês
| MEDLINE
| ID: mdl-29783757
17.
Pharmacological Inhibition of NOS Activates ASK1/JNK Pathway Augmenting Docetaxel-Mediated Apoptosis in Triple-Negative Breast Cancer.
Clin Cancer Res;
24(5): 1152-1162, 2018 03 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-29301832
18.
Phase I and Biomarker Study of Plerixafor and Bevacizumab in Recurrent High-Grade Glioma.
Clin Cancer Res;
24(19): 4643-4649, 2018 10 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-29941486
19.
Prospective Feasibility Trial for Genomics-Informed Treatment in Recurrent and Progressive Glioblastoma.
Clin Cancer Res;
24(2): 295-305, 2018 01 15.
Artigo
em Inglês
| MEDLINE
| ID: mdl-29074604
20.
Phase 1 and pharmacokinetic study of intravenous irinotecan in refractory solid tumor patients with hepatic dysfunction.
Clin Cancer Res;
12(12): 3782-91, 2006 Jun 15.
Artigo
em Inglês
| MEDLINE
| ID: mdl-16778106